当前位置:
X-MOL 学术
›
Nat. Rev. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Camrelizumab plus famitinib to treat RCC.
Nature Reviews Urology ( IF 15.3 ) Pub Date : 2021-10-01 , DOI: 10.1038/s41585-021-00517-6 Timothy Thomas 1
中文翻译:
Camrelizumab加法米替尼治疗RCC。
更新日期:2021-08-27
Nature Reviews Urology ( IF 15.3 ) Pub Date : 2021-10-01 , DOI: 10.1038/s41585-021-00517-6 Timothy Thomas 1
Affiliation
中文翻译:
Camrelizumab加法米替尼治疗RCC。